Bio-Techne (TECH) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04% |
| Dec 31, 2025 | -12.35% |
| Sep 30, 2025 | -13.29% |
| Jun 30, 2025 | -22.40% |
| Mar 31, 2025 | 1.75% |
| Dec 31, 2024 | -14.08% |
| Sep 30, 2024 | -2.71% |
| Jun 30, 2024 | 8.99% |
| Mar 31, 2024 | 27.26% |
| Dec 31, 2023 | 26.42% |
| Sep 30, 2023 | 26.54% |
| Jun 30, 2023 | 13.23% |
| Mar 31, 2023 | 27.34% |
| Dec 31, 2022 | -0.72% |
| Sep 30, 2022 | 12.63% |
| Jun 30, 2022 | 18.25% |
| Mar 31, 2022 | 30.33% |
| Dec 31, 2021 | 28.94% |
| Sep 30, 2021 | 19.97% |
| Jun 30, 2021 | 29.95% |
| Mar 31, 2021 | 30.18% |
| Dec 31, 2020 | 18.55% |
| Sep 30, 2020 | 12.31% |
| Jun 30, 2020 | 20.17% |
| Mar 31, 2020 | 13.52% |
| Dec 31, 2019 | 35.90% |
| Sep 30, 2019 | 16.50% |
| Jun 30, 2019 | 40.95% |
| Mar 31, 2019 | 2.94% |
| Dec 31, 2018 | 4.77% |
| Sep 30, 2018 | 1.91% |
| Jun 30, 2018 | 1.71% |
| Mar 31, 2018 | -11.26% |
| Dec 31, 2017 | -5.08% |
| Sep 30, 2017 | 15.96% |
| Jun 30, 2017 | 38.95% |
| Mar 31, 2017 | 20.40% |
| Dec 31, 2016 | 5.33% |
| Sep 30, 2016 | 17.38% |
| Jun 30, 2016 | 19.13% |
| Mar 31, 2016 | 36.80% |
| Dec 31, 2015 | 46.96% |
| Sep 30, 2015 | 42.22% |
| Jun 30, 2015 | 43.92% |
| Mar 31, 2015 | 29.23% |
| Dec 31, 2014 | 14.57% |
| Sep 30, 2014 | 54.18% |